Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C Gag Vaccine in Healthy HIV-1-Uninfected Adults
Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00258-12
Full Text
Open PDFAbstract
Available in full text
Date
August 22, 2012
Authors
Publisher
American Society for Microbiology